title: A Significant Metabolic and Radiological Response after a Novel Targeted MicroRNA-based Treatment Approach in Malignant Pleural Mesothelioma.
authors.affiliation: 1 Chris O'Brien Lifehouse Sydney, Australia.|2 Asbestos Diseases Research Institute Sydney, Australia.|3 University of Sydney Sydney, Australia.
authors.forename: Steven C
authors.initials: SC
authors.lastname: Kao
authors.affiliation: 3 University of Sydney Sydney, Australia.|4 Royal Prince Alfred Hospital Sydney, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Fulham
authors.affiliation: 4 Royal Prince Alfred Hospital Sydney, Australia.
authors.forename: Kirby
authors.initials: K
authors.lastname: Wong
authors.affiliation: 3 University of Sydney Sydney, Australia.|4 Royal Prince Alfred Hospital Sydney, Australia.|5 University of Western Sydney Sydney, Australia.
authors.forename: Wendy
authors.initials: W
authors.lastname: Cooper
authors.affiliation: 6 EnGeneIC Ltd. Sydney, Australia.
authors.forename: Himanshu
authors.initials: H
authors.lastname: Brahmbhatt
authors.affiliation: 6 EnGeneIC Ltd. Sydney, Australia.
authors.forename: Jennifer
authors.initials: J
authors.lastname: MacDiarmid
authors.affiliation: 6 EnGeneIC Ltd. Sydney, Australia.
authors.forename: Scott
authors.initials: S
authors.lastname: Pattison
authors.affiliation: 1 Chris O'Brien Lifehouse Sydney, Australia.
authors.forename: Jin Og
authors.initials: JO
authors.lastname: Sagong
authors.affiliation: 2 Asbestos Diseases Research Institute Sydney, Australia.
authors.forename: Yennie
authors.initials: Y
authors.lastname: Huynh
authors.affiliation: 2 Asbestos Diseases Research Institute Sydney, Australia.
authors.forename: Felicity
authors.initials: F
authors.lastname: Leslie
authors.affiliation: 3 University of Sydney Sydney, Australia.|7 Royal North Shore Hospital Sydney, Australia.
authors.forename: Nick
authors.initials: N
authors.lastname: Pavlakis
authors.affiliation: 3 University of Sydney Sydney, Australia.|7 Royal North Shore Hospital Sydney, Australia.
authors.forename: Stephen
authors.initials: S
authors.lastname: Clarke
authors.affiliation: 1 Chris O'Brien Lifehouse Sydney, Australia.|3 University of Sydney Sydney, Australia.
authors.forename: Michael
authors.initials: M
authors.lastname: Boyer
authors.affiliation: 2 Asbestos Diseases Research Institute Sydney, Australia.|3 University of Sydney Sydney, Australia.
authors.forename: Glen
authors.initials: G
authors.lastname: Reid
authors.affiliation: 2 Asbestos Diseases Research Institute Sydney, Australia.|3 University of Sydney Sydney, Australia.
authors.forename: Nico
authors.initials: N
authors.lastname: van Zandwijk
mesh_terms: D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D008297:Male; D008654:Mesothelioma / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D000086002:Mesothelioma, Malignant; D035683:MicroRNAs / Q000627:therapeutic use*; D008875:Middle Aged; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D035683:MicroRNAs